Focus on Artificial Intelligence

The Institute of Electrical and Electronics Engineers recently published a new standard that establishes processes to help define, measure, and mitigate algorithmic bias while promoting transparency and accountability throughout the artificial intelligence system lifecycle.

If organizations do not adhere to compliance requirements under the Act, they may be subject to substantial penalties.

Following through on its commitment to charge public companies for artificial intelligence (AI) washing, the US Securities and Exchange Commission (SEC) settled charges against a public company for allegedly misstating material facts about the company’s flagship AI in public statements.

On January 23, 2025, President Donald Trump signed the Executive Order Removing Barriers to American Leadership in Artificial Intelligence.

A concise look the House's AI Task Force, and the report's finding and recommendations.

The US Department of Justice’s Antitrust Division recently updated its guidance on the evaluation of corporate compliance programs for criminal antitrust violations, which federal prosecutors use to evaluate the compliance efforts of corporate subjects of the department’s criminal investigations.

Having advised numerous companies on AI governance, compliance, and regulation, our key to solving AI compliance issues has been the creation of a systematic approach: the Standardized Assessment and Governance Enhancement (SAGE) framework.

SB 1120 mandates that only licensed healthcare professionals may make medical necessity determinations, ensuring AI tools may not independently deny, delay, or modify healthcare services based on medical necessity.

The House Science, Space, and Technology Committee has approved nine bills intended to advance global US leadership in the development and deployment of artificial intelligence.

Details on the Nondiscrimination in Health Programs and Activities Final Rule.

The new law goes into effect until February 1, 2026.

The roadmap aims to provide a broad framework for senators and committees as they develop legislation targeted at specific aspects of both the promise and the potential harms of, AI.

In this webinar, the chairs of the 2024 Life Sciences AI Summit will discuss the implications for the life sciences industry arising from President Biden’s landmark October 30 Executive Order on Artificial Intelligence. From funding research, to signaling new obligations on pre-and post-market life sciences AI, the Executive Order directs multiple federal agencies to roll out new regulations – and suggests the contours of potential future legislation to come.

The intersection of artificial intelligence (AI) and life sciences is heavily influenced by FDA regulatory considerations, and further change is anticipated to continually impact biotech, biologics, life sciences, and medical device companies.

During its last week before the inauguration, the Biden Administration issued significant and complex new export controls on semiconductors and related technology for artificial intelligence applications worldwide.

The draft guidance provides recommendations on how FDA plans to apply a risk-based credibility assessment framework to evaluate the use of artificial intelligence (AI) models that produce information or data intended to support regulatory decision-making regarding safety, effectiveness, or quality of drugs and biological products.

DLA Piper hosted a webinar that explored AI’s impact on drug development and the life sciences industry.

Red teaming involves deliberately probing an AI model to test the limits of its capabilities. Our handbook explores how your company may make best use of this approach and become red team ready.

We explore how to navigate AI in the workplace, with a focus on employee wellbeing, in the latest episode of our AI and Employment podcast.

In this episode, Jonathan Exten-Wright, Jen Holyoake, Hans-Peter Löw and Nils Grunicke explore recruitment and bias and how AI is reshaping hiring practices. They also discuss key considerations when implementing AI, alongside risk mitigation.

The US Commodity Futures Trading Commission issued a nonbinding staff advisory to all CFTC-registered entities and registrants concerning the use of artificial intelligence in CFTC-regulated markets.

Our new report, in collaboration with TMT Finance, captures the factors driving market demand worldwide, focusing on data center investment opportunities, challenges, and emerging trends.

In this episode, our speakers discuss the evolution of pricing algorithms and why algorithms are often criticized for being anti-competitive or collusive.

Stay informed and ahead of the curve in the rapidly evolving world of Artificial Intelligence (AI). This four-part video series offers valuable knowledge and practical insights that can help you navigate and leverage AI innovations in your professional field.